You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

CORRECTION article

Front. Pharmacol., 27 February 2024

Sec. Pharmacogenetics and Pharmacogenomics

Volume 15 - 2024 | https://doi.org/10.3389/fphar.2024.1385698

Corrigendum: Precision medicine: a new era for inner ear diseases

  • 1. Department of Molecular Medicine, University of Pavia, Pavia, Italy

  • 2. ICS-Maugeri IRCCS, Pavia, Italy

  • 3. Department of Biology and Biotechnology “Lazzaro Spallanzani”, University of Pavia, Pavia, Italy

  • 4. Istituto Nazionale di Fisica Nucleare, Sezione di Pavia, Pavia, Italy

  • 5. Department of Anatomy and Cell Biology, University of Illinois at Chicago, Chicago, IL, United States

  • 6. Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy

  • 7. Nanomedicine Center, Neuroscience Center, School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy

  • 8. Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy

Article metrics

View details

1

Citations

1,1k

Views

384

Downloads

In the published article, there was an error in the Funding statement. The CUP numbers were missed. “The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The fee of this publication is supported by the following grants: FIS. SPAIA.PRIN 2022; PRIN 2022 funded by the European Union–Next-Generation EU, PRIN 20228AAJRL; PRIN 2022 funded by the European Union–Next-Generation EU, 2023-ATEQC-0026—multifunctional nanocarriers as advanced biomaterials for targeted and therapeutic RNA delivery [MixnMatch] financed to: SP, MS, and SG respectively” and include original text. The correct Funding statement appears below.

Statements

Funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. The fee of this publication is supported by the following grants: FIS. SPAIA.PRIN 2022; PRIN 2022 funded by the European Union–Next-Generation EU, CUP F53D23006030001; PRIN 20228AAJRL; PRIN 2022 funded by the European Union–Next-Generation EU, CUP F53D23005930006; 2023-ATEQC-0026—multifunctional nanocarriers as advanced biomaterials for targeted and therapeutic RNA delivery [MixnMatch] financed to: SP, MS, and SG respectively.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

vestibule, cochlea, inner ear, nanoparticles, microneedles, precision medicine

Citation

Tavazzani E, Spaiardi P, Contini D, Sancini G, Russo G and Masetto S (2024) Corrigendum: Precision medicine: a new era for inner ear diseases. Front. Pharmacol. 15:1385698. doi: 10.3389/fphar.2024.1385698

Received

13 February 2024

Accepted

14 February 2024

Published

27 February 2024

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

15 - 2024

Updates

Copyright

*Correspondence: Elisa Tavazzani, ; Paolo Spaiardi,

†These authors have contributed equally to this work and share first authorship

‡These authors share senior authorship

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics